Health is our business
7 Mar/ 0 Comment/ 258 Hits/
The anti-infective team of Pfizer Company, in collaboration with Arak University of Medical Sciences held a program to manage drug-resistant infections on Friday, December 17, 2021.
The program started at 10:00 AM with a speech by Dr. Behnaz Mahmoudi, head of the medical team of Pfizer anti-infective team, about Tygecycline drug and its effectiveness in drug-resistant infections. Dr. Shabani, Immune Deficiency and Transplant Fellowship, introduced a patient with severe secondary sepsis to PDR microorganism. This program was welcomed by infectious disease professors in Arak and all over the country, and at the end of the program, the slides were given to the audience.